Amoxil Articles
GlaxoSmithKline sells US penicillin facility and products to India’s Dr Reddy’s; GSK favored in Paxil trial
24 November 2010
13.7% growth for Indian pharma recorded 13.7%to $9.43 billion in first three quarters of fiscal 2009-10
4 February 2010
Philippines seeks more voluntary drug price reductions
19 January 2010
GlaxoSmithKline beats forecasts with 3rd quarter2009 profits leaping 34%, despite generic competition
28 October 2009
China publishes Essential Drugs list of 307 products
25 August 2009
Japan stock market week to March 23, 2009
30 March 2009
Takeda files Japanese NDA for H. Pylori combo
30 March 2009
MiddleBrook launches Moxatag, first ER amoxicillin
23 March 2009
BMP Sunstone acquires 50% of Shengda
26 January 2009
Middlebrook to launch Moxatag in March
12 January 2009
US FDA guidance for old antibiotic patents
15 December 2008
MiddleBrook closes $100M financing
15 September 2008
Thomson releases Pharma Matters reports for 1st qtr
1 September 2008
Safeway joins the $4 per month US generic Rx sale
16 June 2008
Vietnam to resist drug price hike calls
2 June 2008
MiddleBrook closes $21M placing
4 February 2008
MiddleBrook Pharma raises $21M
4 February 2008
PhRMA details Mexico flood relief by members
17 December 2007
Headlines 25 years ago this week....
5 November 2007
Oscient completes Ph IV enrollment in Factive trial early
5 February 2007
French antibiotics consumption falls
8 January 2007
UPDATE: $4 generic price war spreads across USA
27 November 2006
Wal-Mart expands $4 generic plan but comes under fire
27 November 2006
Indian Pharma cuts 886 drug prices
13 November 2006
US study finds 700,000 adverse effects cases
30 October 2006
UPDATE: ICAAC 2006 sees strong data on next-gen antibiotics: Tygacil, ceftaroline, cethromycin
9 October 2006
Strong efficacy data for S-P's Avelox
9 October 2006
Headlines 25 years ago this week....
5 June 2006
Headlines 25 years ago this week....
8 May 2006
Japan recalculates eight drug ingredients due to high sales
27 February 2006
19 additions to Italy's reimbursement list
20 February 2006
Par terminates amoxicillin deal with Advancis
15 August 2005
Advancis/Par's PULSYS misses Ph III endpoint
27 June 2005
GSK Philippines plans to boost sales 10%
27 June 2005
Advancis Pharma raises $27M
26 April 2005
Advancis finds commercial source for Amoxicllin PULSYS
25 April 2005
Advancis completes PULSYS trial enrollment
22 April 2005
Japan stock market week to March 21
28 March 2005
Generic approvals for Mylan and Teva
21 February 2005
Advancis to launch Ph III trial of pediatric amoxcicillin
10 January 2005
Spain's Reig Jofre buys Antibioticos Farma's antibiotics brands
11 October 2004
One in 10 children in UK at risk of undetected ADRs
4 October 2004
Oscient's Factive available in USA
20 September 2004
Factive effective for CAP and ABECB
16 August 2004
Bayer's Avelox superior in AECB
15 March 2004
GSK cuts 15 drug prices in Philippines
1 March 2004
GSK results in line with company guidance; shares fall on 16% drop in 4th-qtr income
23 February 2004
US OK for Ranbaxy's generic amoxicillin and clavulanate
22 December 2003
GSK 2nd-qtr earnings beat forecasts
28 July 2003
Novartis and GSK settle on Augmentin
21 July 2003
Ranbaxy revises target on US sales
14 July 2003
Novartis/GSK Augmentin dispute will now go to trial
23 June 2003
Teva sales grow 39%, EPS up 56% in 1st qtr
12 May 2003
Stock Commentary - Europe
21 April 2003
Pliva closes deal to acquire Spain's Edigen
7 April 2003
New Augmentin generic for Ranbaxy
31 March 2003
IVAX seeks approval for generic Flonase
17 March 2003
Argentine Rx prices fall as generics law bites
17 March 2003
French generic drugs market expanding
10 March 2003
Generic drug sales take off in Brazil
3 March 2003
Earnings up at Teva on strong generic sales
24 February 2003
Update: GSK 2002 results boosted by 13% growth in US sales
17 February 2003
GlaxoSmithKline 2002 results boosted by 13% growth in US sales
17 February 2003
Pliva to buy generics firm in Spain
17 February 2003
Aventis wins advisory panel backing for multiple Ketek claims
13 January 2003
Lek takes on GSK's Augmentin in USA
13 January 2003
Geneva says its generic Augmentin is USA's first
22 July 2002
GSK to sue over generic Augmentin launch?
22 July 2002
Stock Commentary - Europe
10 June 2002
Stock Commentary - Europe
3 June 2002
First Euro approval for Bayer's Avalox IV
13 May 2002
Ad firm defends the pharma industry
29 April 2002
France's top-selling Rx drugs in 2001
15 April 2002
Stock Commentary - Europe
25 March 2002
UK nurse Rxers' list widens to antibiotics
25 February 2002
Lek turnover up 24% in first nine months
29 November 2001
Pfizer's one-day Zithromax course squeaks through FDA advisory panel
12 November 2001
DSM seeks FDA OK for Indian amoxicillin plant
30 October 2001
Indian firms prepare to make anti-anthrax drugs
24 October 2001
Advancis Pharmaceutical and TIGR sign antibiotic research deal
26 September 2001
Novartis unit taking on GSK over patents
12 June 2001
GSK restructuring its R&D to boost productivity
22 February 2001
Analysts expectant on future prospects for Canada's Axcan Pharma
13 February 2001
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
